Atlas Trials

Recurrent Childhood Central Nervous System Neoplasm

5 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Childhood Central Nervous System Neoplasm

RecordFirmDate
Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) (NCT03220035)National Cancer Institute (NCI)2017-11-08
Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) (NCT03213691)National Cancer Institute (NCI)2017-10-30
Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial) (NCT03233204)National Cancer Institute (NCI)2017-09-14
Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas (NCT02323880)Children's Oncology Group2015-10-30
Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies (NCT02116777)National Cancer Institute (NCI)2014-05-16

Track Recurrent Childhood Central Nervous System Neoplasm automatically

Every clearance here is in the API, with alerts when new ones post.